VIVO
Index
Log in
Search form
Home
People
Organizations
Research
Events
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Patients with Mild to Moderate Alzheimer’s Disease Who Are APOE Carriers, Elan.
Grant
Affiliation
Affiliation
contributor
Calder, Christopher
Sub-investigator
- 2008